Abstract Body

Despite combination antiretroviral therapy (cART) with suppressed viral replication, gut microbiota alterations, microbial translocation and low-grade inflammation persist in several HIV-infected individuals. The aim of this study was to investigate the effects of the probiotic strain Lactobacillus rhamnosus GG (LGG) on the gut microbiota composition, microbial translocation and intestinal inflammation.

The gut microbiota composition (Illumina sequencing of 16s rRNA) and level of microbial translocation (lipopolysaccharide, LPS) were determined at baseline and after probiotic intervention in 45 individuals (15 cART näive and 30 cART-treated). All study participants received 6 x 109 colony-forming units of LGG twice daily for eight weeks. Gut microbial profiles were compared with measurements of intestinal inflammation by 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography/magnetic resonance imaging (18FDG PET/MRI) scans in 15 individuals.

After probiotic intervention, no overall change in microbial translocation (LPS) or microbial alpha diversity could be detected in the study group (observed operational taxonomic units (OTUs); mean change -0.83, 95% CI -2.33 to 0.67, p=0.328, phylogenetic diversity (PD) whole tree; mean change -10.96, 95% CI -33.33 to 11.41, p=0.270). However, a significant decrease in intestinal inflammation was detected on PET/MRI (-0.3 mean difference in combined activity grade score from six regions, P=0.006), along with a reduction in the bacterial families Enterobacteriaceae (p=0.018) and Erysipelotrichaceae (p=0.037) after probiotic intervention. Comparing individuals with decreased 18F-FDG-uptake on PET/MRI (good responders) with individuals with no change in uptake after intervention (poor responders), there was a significant reduction in the relative abundance of Enterobacteriaceae (p=0.048), but not Erysipelotrichaceae, in the gut microbiome of the good responders.

Reduced abundance of Enterobacteriaceae after probiotic intervention could potentially explain the local anti-inflammatory effect in the gut, as this bacterial family contains several known pathogenic strains. These findings are in line with the measured PET/MRI activity in the gut.